Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 2
2012 2
2013 1
2014 6
2015 2
2016 15
2017 11
2018 13
2019 16
2020 15
2021 22
2022 17
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 34857656

104 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Trotman J, Barrington SF, Belada D, Meignan M, MacEwan R, Owen C, Ptáčník V, Rosta A, Fingerle-Rowson GR, Zhu J, Nielsen T, Sahin D, Hiddemann W, Marcus RE, Davies A; PET investigators from the GALLIUM study. Trotman J, et al. Lancet Oncol. 2018 Nov;19(11):1530-1542. doi: 10.1016/S1470-2045(18)30618-1. Epub 2018 Oct 8. Lancet Oncol. 2018. PMID: 30309758
Role of 18F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma.
Houard C, Pinaquy JB, Mesguich C, Henriques de Figueiredo B, Cazeau AL, Allard JB, Laharie H, Bordenave L, Fernandez P, Vendrely V. Houard C, et al. J Nucl Med. 2017 Sep;58(9):1414-1420. doi: 10.2967/jnumed.116.185280. Epub 2017 Mar 9. J Nucl Med. 2017. PMID: 28280225 Free article.
Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.
Trotman J, Fournier M, Lamy T, Seymour JF, Sonet A, Janikova A, Shpilberg O, Gyan E, Tilly H, Estell J, Forsyth C, Decaudin D, Fabiani B, Gabarre J, Salles B, Van Den Neste E, Canioni D, Garin E, Fulham M, Vander Borght T, Salles G. Trotman J, et al. J Clin Oncol. 2011 Aug 10;29(23):3194-200. doi: 10.1200/JCO.2011.35.0736. Epub 2011 Jul 11. J Clin Oncol. 2011. PMID: 21747087
FDG PET/CT predictive role in follicular lymphoma.
Lopci E, Zanoni L, Chiti A, Fonti C, Santi I, Zinzani PL, Fanti S. Lopci E, et al. Eur J Nucl Med Mol Imaging. 2012 May;39(5):864-71. doi: 10.1007/s00259-012-2079-y. Epub 2012 Feb 22. Eur J Nucl Med Mol Imaging. 2012. PMID: 22354449
Basal (18)F-FDG PET/CT in follicular lymphoma: A comparison of metabolic and clinical variables in the prognostic assessment.
Jiménez Londoño GA, García Vicente AM, Poblete García VM, Amo-Salas M, Calle Primo C, Ibañez García Á, Martínez Sanchís B, López-Fidalgo JF, Solano Ramos F, Martínez Hellín A, Díaz Morfa M, Soriano Castrejón Á. Jiménez Londoño GA, et al. Rev Esp Med Nucl Imagen Mol. 2016 Sep-Oct;35(5):298-305. doi: 10.1016/j.remn.2016.04.003. Epub 2016 Jun 14. Rev Esp Med Nucl Imagen Mol. 2016. PMID: 27312693 English, Spanish.
104 results